<DOC>
	<DOC>NCT02781922</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of intracoronary injection of JRM-001 after reconstructive surgery in pediatric patients with functional single ventricle</brief_summary>
	<brief_title>Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)</brief_title>
	<detailed_description />
	<mesh_term>Hypoplastic Left Heart Syndrome</mesh_term>
	<criteria>Functional single ventricle patient with heart failure who is scheduled for stage 2 (Glenn) or stage 3 (Fontan) surgery EF(%) by echocardiography â‰¤ 55% Able to obtain written informed consent of participation in the study by a parent of the patient Known medical history of cardiogenic shock Lethal, uncontrollable arrhythmia Complication of coronary artery disease Eisenmenger syndrome Complication of brain dysfunction due to circulatory failure Malignant neoplasm Complication of severe neurologic disorder Severe pulmonary embolism or pulmonary hypertension Severe renal failure Multiple organ failure Active infection (including endocarditis) Sepsis Active hemorrhagic disease (e.g. gastrointestinal bleeding, injury) Known history of hypersensitivity to antiinfective drugs Inability to complete the protocol treatment and baseline to followup examinations</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>cardiac stem/progenitor cells</keyword>
	<keyword>autologous cell therapy</keyword>
	<keyword>functional single ventricle</keyword>
	<keyword>congenital heart disease</keyword>
</DOC>